The biologics and biosimilars market represents a rapidly growing sector in the global pharmaceutical industry. Biologics, derived from living organisms, include products such as monoclonal antibodies, vaccines, and recombinant proteins, used to treat chronic diseases like cancer, diabetes, and autoimmune disorders. Biosimilars are highly similar, cost-effective alternatives to branded...